Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for improvement of the organ donation process
ISRCTN66157570Phase 3Completed
- Sponsor
- Fundación Mutua Madrileña
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Melatonin with Placebo (2 arms). Primary endpoints: Number of valid organs for donation per donor, Functionality of each organ at 6 months after transplant and 1 more. Started Mar 2018; status: completed.
02
Drugs
melatonin
Beyond the preview
Go deeper on ISRCTN66157570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN66157570.